Global Pneumococcal Vaccine Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Pneumococcal Vaccine market size was valued at US$ 7043.6 million in 2023. With growing demand in downstream market, the Pneumococcal Vaccine is forecast to a readjusted size of US$ 7625.9 million by 2030 with a CAGR of 1.1% during review period.
The research report highlights the growth potential of the global Pneumococcal Vaccine market. Pneumococcal Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Pneumococcal Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Pneumococcal Vaccine market.
Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.
There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines.
23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK).
At present, only MSD, Sanofipasteur and CDIBP can produce PPSV 23, and they hold key technologies and patents, with high-end customers, have been formed in the monopoly position in the industry. As for PCV 13, only Pfizer can supply it. And GSK is the only one manufacturing PCV 10. However, there are some companies working on research of Pneumococcal Vaccine. Pfizer is the leader of this industry with 84% market shares.
North America is the largest consumption market of Pneumococcal Vaccine with sales market share nearly 40%. The second place is Europe, following North America with sales market share over 18%. Asia-Pacific is another important market of Pneumococcal Vaccine, enjoy nearly 16% sales market share, but the consumption experienced a sharp decrease due to approval of government departments in last few years.
Key Features:
The report on Pneumococcal Vaccine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Pneumococcal Vaccine market. It may include historical data, market segmentation by Type (e.g., PPSV 23, PCV 7/13), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Pneumococcal Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Pneumococcal Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Pneumococcal Vaccine industry. This include advancements in Pneumococcal Vaccine technology, Pneumococcal Vaccine new entrants, Pneumococcal Vaccine new investment, and other innovations that are shaping the future of Pneumococcal Vaccine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Pneumococcal Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for Pneumococcal Vaccine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Pneumococcal Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Pneumococcal Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Pneumococcal Vaccine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Pneumococcal Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Pneumococcal Vaccine market.
Market Segmentation:
Pneumococcal Vaccine market is split by Type and by End User. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by End User in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Pneumococcal Vaccine market?
What factors are driving Pneumococcal Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pneumococcal Vaccine market opportunities vary by end market size?
How does Pneumococcal Vaccine break out type, end user?
According to our LPI (LP Information) latest study, the global Pneumococcal Vaccine market size was valued at US$ 7043.6 million in 2023. With growing demand in downstream market, the Pneumococcal Vaccine is forecast to a readjusted size of US$ 7625.9 million by 2030 with a CAGR of 1.1% during review period.
The research report highlights the growth potential of the global Pneumococcal Vaccine market. Pneumococcal Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Pneumococcal Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Pneumococcal Vaccine market.
Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.
There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines.
23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK).
At present, only MSD, Sanofipasteur and CDIBP can produce PPSV 23, and they hold key technologies and patents, with high-end customers, have been formed in the monopoly position in the industry. As for PCV 13, only Pfizer can supply it. And GSK is the only one manufacturing PCV 10. However, there are some companies working on research of Pneumococcal Vaccine. Pfizer is the leader of this industry with 84% market shares.
North America is the largest consumption market of Pneumococcal Vaccine with sales market share nearly 40%. The second place is Europe, following North America with sales market share over 18%. Asia-Pacific is another important market of Pneumococcal Vaccine, enjoy nearly 16% sales market share, but the consumption experienced a sharp decrease due to approval of government departments in last few years.
Key Features:
The report on Pneumococcal Vaccine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Pneumococcal Vaccine market. It may include historical data, market segmentation by Type (e.g., PPSV 23, PCV 7/13), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Pneumococcal Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Pneumococcal Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Pneumococcal Vaccine industry. This include advancements in Pneumococcal Vaccine technology, Pneumococcal Vaccine new entrants, Pneumococcal Vaccine new investment, and other innovations that are shaping the future of Pneumococcal Vaccine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Pneumococcal Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for Pneumococcal Vaccine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Pneumococcal Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Pneumococcal Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Pneumococcal Vaccine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Pneumococcal Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Pneumococcal Vaccine market.
Market Segmentation:
Pneumococcal Vaccine market is split by Type and by End User. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by End User in terms of volume and value.
Segmentation by type
- PPSV 23
- PCV 7/13
- PCV 10
- Child
- Adult
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- GSK
- MSD
- Sanofipasteur
- CDIBP
What is the 10-year outlook for the global Pneumococcal Vaccine market?
What factors are driving Pneumococcal Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pneumococcal Vaccine market opportunities vary by end market size?
How does Pneumococcal Vaccine break out type, end user?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pneumococcal Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Pneumococcal Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Pneumococcal Vaccine by Country/Region, 2019, 2023 & 2030
2.2 Pneumococcal Vaccine Segment by Type
2.2.1 PPSV
2.2.2 PCV 7/13
2.2.3 PCV
2.3 Pneumococcal Vaccine Sales by Type
2.3.1 Global Pneumococcal Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global Pneumococcal Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Pneumococcal Vaccine Sale Price by Type (2019-2024)
2.4 Pneumococcal Vaccine Segment by End User
2.4.1 Child
2.4.2 Adult
2.5 Pneumococcal Vaccine Sales by End User
2.5.1 Global Pneumococcal Vaccine Sale Market Share by End User (2019-2024)
2.5.2 Global Pneumococcal Vaccine Revenue and Market Share by End User (2019-2024)
2.5.3 Global Pneumococcal Vaccine Sale Price by End User (2019-2024)
3 GLOBAL PNEUMOCOCCAL VACCINE BY COMPANY
3.1 Global Pneumococcal Vaccine Breakdown Data by Company
3.1.1 Global Pneumococcal Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global Pneumococcal Vaccine Sales Market Share by Company (2019-2024)
3.2 Global Pneumococcal Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global Pneumococcal Vaccine Revenue by Company (2019-2024)
3.2.2 Global Pneumococcal Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global Pneumococcal Vaccine Sale Price by Company
3.4 Key Manufacturers Pneumococcal Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pneumococcal Vaccine Product Location Distribution
3.4.2 Players Pneumococcal Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PNEUMOCOCCAL VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Pneumococcal Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global Pneumococcal Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Pneumococcal Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Pneumococcal Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global Pneumococcal Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Pneumococcal Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Pneumococcal Vaccine Sales Growth
4.4 APAC Pneumococcal Vaccine Sales Growth
4.5 Europe Pneumococcal Vaccine Sales Growth
4.6 Middle East & Africa Pneumococcal Vaccine Sales Growth
5 AMERICAS
5.1 Americas Pneumococcal Vaccine Sales by Country
5.1.1 Americas Pneumococcal Vaccine Sales by Country (2019-2024)
5.1.2 Americas Pneumococcal Vaccine Revenue by Country (2019-2024)
5.2 Americas Pneumococcal Vaccine Sales by Type
5.3 Americas Pneumococcal Vaccine Sales by End User
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pneumococcal Vaccine Sales by Region
6.1.1 APAC Pneumococcal Vaccine Sales by Region (2019-2024)
6.1.2 APAC Pneumococcal Vaccine Revenue by Region (2019-2024)
6.2 APAC Pneumococcal Vaccine Sales by Type
6.3 APAC Pneumococcal Vaccine Sales by End User
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pneumococcal Vaccine by Country
7.1.1 Europe Pneumococcal Vaccine Sales by Country (2019-2024)
7.1.2 Europe Pneumococcal Vaccine Revenue by Country (2019-2024)
7.2 Europe Pneumococcal Vaccine Sales by Type
7.3 Europe Pneumococcal Vaccine Sales by End User
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pneumococcal Vaccine by Country
8.1.1 Middle East & Africa Pneumococcal Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Pneumococcal Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa Pneumococcal Vaccine Sales by Type
8.3 Middle East & Africa Pneumococcal Vaccine Sales by End User
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pneumococcal Vaccine
10.3 Manufacturing Process Analysis of Pneumococcal Vaccine
10.4 Industry Chain Structure of Pneumococcal Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pneumococcal Vaccine Distributors
11.3 Pneumococcal Vaccine Customer
12 WORLD FORECAST REVIEW FOR PNEUMOCOCCAL VACCINE BY GEOGRAPHIC REGION
12.1 Global Pneumococcal Vaccine Market Size Forecast by Region
12.1.1 Global Pneumococcal Vaccine Forecast by Region (2025-2030)
12.1.2 Global Pneumococcal Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pneumococcal Vaccine Forecast by Type
12.7 Global Pneumococcal Vaccine Forecast by End User
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Pneumococcal Vaccine Product Portfolios and Specifications
13.1.3 Pfizer Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Pneumococcal Vaccine Product Portfolios and Specifications
13.2.3 GSK Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 MSD
13.3.1 MSD Company Information
13.3.2 MSD Pneumococcal Vaccine Product Portfolios and Specifications
13.3.3 MSD Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 MSD Main Business Overview
13.3.5 MSD Latest Developments
13.4 Sanofipasteur
13.4.1 Sanofipasteur Company Information
13.4.2 Sanofipasteur Pneumococcal Vaccine Product Portfolios and Specifications
13.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Sanofipasteur Main Business Overview
13.4.5 Sanofipasteur Latest Developments
13.5 CDIBP
13.5.1 CDIBP Company Information
13.5.2 CDIBP Pneumococcal Vaccine Product Portfolios and Specifications
13.5.3 CDIBP Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 CDIBP Main Business Overview
13.5.5 CDIBP Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pneumococcal Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Pneumococcal Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Pneumococcal Vaccine by Country/Region, 2019, 2023 & 2030
2.2 Pneumococcal Vaccine Segment by Type
2.2.1 PPSV
2.2.2 PCV 7/13
2.2.3 PCV
2.3 Pneumococcal Vaccine Sales by Type
2.3.1 Global Pneumococcal Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global Pneumococcal Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Pneumococcal Vaccine Sale Price by Type (2019-2024)
2.4 Pneumococcal Vaccine Segment by End User
2.4.1 Child
2.4.2 Adult
2.5 Pneumococcal Vaccine Sales by End User
2.5.1 Global Pneumococcal Vaccine Sale Market Share by End User (2019-2024)
2.5.2 Global Pneumococcal Vaccine Revenue and Market Share by End User (2019-2024)
2.5.3 Global Pneumococcal Vaccine Sale Price by End User (2019-2024)
3 GLOBAL PNEUMOCOCCAL VACCINE BY COMPANY
3.1 Global Pneumococcal Vaccine Breakdown Data by Company
3.1.1 Global Pneumococcal Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global Pneumococcal Vaccine Sales Market Share by Company (2019-2024)
3.2 Global Pneumococcal Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global Pneumococcal Vaccine Revenue by Company (2019-2024)
3.2.2 Global Pneumococcal Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global Pneumococcal Vaccine Sale Price by Company
3.4 Key Manufacturers Pneumococcal Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pneumococcal Vaccine Product Location Distribution
3.4.2 Players Pneumococcal Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PNEUMOCOCCAL VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Pneumococcal Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global Pneumococcal Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Pneumococcal Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Pneumococcal Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global Pneumococcal Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Pneumococcal Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Pneumococcal Vaccine Sales Growth
4.4 APAC Pneumococcal Vaccine Sales Growth
4.5 Europe Pneumococcal Vaccine Sales Growth
4.6 Middle East & Africa Pneumococcal Vaccine Sales Growth
5 AMERICAS
5.1 Americas Pneumococcal Vaccine Sales by Country
5.1.1 Americas Pneumococcal Vaccine Sales by Country (2019-2024)
5.1.2 Americas Pneumococcal Vaccine Revenue by Country (2019-2024)
5.2 Americas Pneumococcal Vaccine Sales by Type
5.3 Americas Pneumococcal Vaccine Sales by End User
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pneumococcal Vaccine Sales by Region
6.1.1 APAC Pneumococcal Vaccine Sales by Region (2019-2024)
6.1.2 APAC Pneumococcal Vaccine Revenue by Region (2019-2024)
6.2 APAC Pneumococcal Vaccine Sales by Type
6.3 APAC Pneumococcal Vaccine Sales by End User
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pneumococcal Vaccine by Country
7.1.1 Europe Pneumococcal Vaccine Sales by Country (2019-2024)
7.1.2 Europe Pneumococcal Vaccine Revenue by Country (2019-2024)
7.2 Europe Pneumococcal Vaccine Sales by Type
7.3 Europe Pneumococcal Vaccine Sales by End User
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pneumococcal Vaccine by Country
8.1.1 Middle East & Africa Pneumococcal Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Pneumococcal Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa Pneumococcal Vaccine Sales by Type
8.3 Middle East & Africa Pneumococcal Vaccine Sales by End User
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pneumococcal Vaccine
10.3 Manufacturing Process Analysis of Pneumococcal Vaccine
10.4 Industry Chain Structure of Pneumococcal Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pneumococcal Vaccine Distributors
11.3 Pneumococcal Vaccine Customer
12 WORLD FORECAST REVIEW FOR PNEUMOCOCCAL VACCINE BY GEOGRAPHIC REGION
12.1 Global Pneumococcal Vaccine Market Size Forecast by Region
12.1.1 Global Pneumococcal Vaccine Forecast by Region (2025-2030)
12.1.2 Global Pneumococcal Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pneumococcal Vaccine Forecast by Type
12.7 Global Pneumococcal Vaccine Forecast by End User
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Pneumococcal Vaccine Product Portfolios and Specifications
13.1.3 Pfizer Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Pneumococcal Vaccine Product Portfolios and Specifications
13.2.3 GSK Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 MSD
13.3.1 MSD Company Information
13.3.2 MSD Pneumococcal Vaccine Product Portfolios and Specifications
13.3.3 MSD Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 MSD Main Business Overview
13.3.5 MSD Latest Developments
13.4 Sanofipasteur
13.4.1 Sanofipasteur Company Information
13.4.2 Sanofipasteur Pneumococcal Vaccine Product Portfolios and Specifications
13.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Sanofipasteur Main Business Overview
13.4.5 Sanofipasteur Latest Developments
13.5 CDIBP
13.5.1 CDIBP Company Information
13.5.2 CDIBP Pneumococcal Vaccine Product Portfolios and Specifications
13.5.3 CDIBP Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 CDIBP Main Business Overview
13.5.5 CDIBP Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pneumococcal Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Pneumococcal Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of PPSV 23
Table 4. Major Players of PCV 7/13
Table 5. Major Players of PCV 10
Table 6. Global Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)
Table 7. Global Pneumococcal Vaccine Sales Market Share by Type (2019-2024)
Table 8. Global Pneumococcal Vaccine Revenue by Type (2019-2024) & ($ million)
Table 9. Global Pneumococcal Vaccine Revenue Market Share by Type (2019-2024)
Table 10. Global Pneumococcal Vaccine Sale Price by Type (2019-2024) & (USD/Dose)
Table 11. Global Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)
Table 12. Global Pneumococcal Vaccine Sales Market Share by End User (2019-2024)
Table 13. Global Pneumococcal Vaccine Revenue by End User (2019-2024)
Table 14. Global Pneumococcal Vaccine Revenue Market Share by End User (2019-2024)
Table 15. Global Pneumococcal Vaccine Sale Price by End User (2019-2024) & (USD/Dose)
Table 16. Global Pneumococcal Vaccine Sales by Company (2019-2024) & (K Doses)
Table 17. Global Pneumococcal Vaccine Sales Market Share by Company (2019-2024)
Table 18. Global Pneumococcal Vaccine Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Pneumococcal Vaccine Revenue Market Share by Company (2019-2024)
Table 20. Global Pneumococcal Vaccine Sale Price by Company (2019-2024) & (USD/Dose)
Table 21. Key Manufacturers Pneumococcal Vaccine Producing Area Distribution and Sales Area
Table 22. Players Pneumococcal Vaccine Products Offered
Table 23. Pneumococcal Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Pneumococcal Vaccine Sales by Geographic Region (2019-2024) & (K Doses)
Table 27. Global Pneumococcal Vaccine Sales Market Share Geographic Region (2019-2024)
Table 28. Global Pneumococcal Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Pneumococcal Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Pneumococcal Vaccine Sales by Country/Region (2019-2024) & (K Doses)
Table 31. Global Pneumococcal Vaccine Sales Market Share by Country/Region (2019-2024)
Table 32. Global Pneumococcal Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Pneumococcal Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Pneumococcal Vaccine Sales by Country (2019-2024) & (K Doses)
Table 35. Americas Pneumococcal Vaccine Sales Market Share by Country (2019-2024)
Table 36. Americas Pneumococcal Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Pneumococcal Vaccine Revenue Market Share by Country (2019-2024)
Table 38. Americas Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)
Table 39. Americas Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)
Table 40. APAC Pneumococcal Vaccine Sales by Region (2019-2024) & (K Doses)
Table 41. APAC Pneumococcal Vaccine Sales Market Share by Region (2019-2024)
Table 42. APAC Pneumococcal Vaccine Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Pneumococcal Vaccine Revenue Market Share by Region (2019-2024)
Table 44. APAC Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)
Table 45. APAC Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)
Table 46. Europe Pneumococcal Vaccine Sales by Country (2019-2024) & (K Doses)
Table 47. Europe Pneumococcal Vaccine Sales Market Share by Country (2019-2024)
Table 48. Europe Pneumococcal Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Pneumococcal Vaccine Revenue Market Share by Country (2019-2024)
Table 50. Europe Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)
Table 51. Europe Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)
Table 52. Middle East & Africa Pneumococcal Vaccine Sales by Country (2019-2024) & (K Doses)
Table 53. Middle East & Africa Pneumococcal Vaccine Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Pneumococcal Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Pneumococcal Vaccine Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)
Table 57. Middle East & Africa Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)
Table 58. Key Market Drivers & Growth Opportunities of Pneumococcal Vaccine
Table 59. Key Market Challenges & Risks of Pneumococcal Vaccine
Table 60. Key Industry Trends of Pneumococcal Vaccine
Table 61. Pneumococcal Vaccine Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Pneumococcal Vaccine Distributors List
Table 64. Pneumococcal Vaccine Customer List
Table 65. Global Pneumococcal Vaccine Sales Forecast by Region (2025-2030) & (K Doses)
Table 66. Global Pneumococcal Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Pneumococcal Vaccine Sales Forecast by Country (2025-2030) & (K Doses)
Table 68. Americas Pneumococcal Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Pneumococcal Vaccine Sales Forecast by Region (2025-2030) & (K Doses)
Table 70. APAC Pneumococcal Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Pneumococcal Vaccine Sales Forecast by Country (2025-2030) & (K Doses)
Table 72. Europe Pneumococcal Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Pneumococcal Vaccine Sales Forecast by Country (2025-2030) & (K Doses)
Table 74. Middle East & Africa Pneumococcal Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Pneumococcal Vaccine Sales Forecast by Type (2025-2030) & (K Doses)
Table 76. Global Pneumococcal Vaccine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Pneumococcal Vaccine Sales Forecast by End User (2025-2030) & (K Doses)
Table 78. Global Pneumococcal Vaccine Revenue Forecast by End User (2025-2030) & ($ Millions)
Table 79. Pfizer Basic Information, Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 80. Pfizer Pneumococcal Vaccine Product Portfolios and Specifications
Table 81. Pfizer Pneumococcal Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 82. Pfizer Main Business
Table 83. Pfizer Latest Developments
Table 84. GSK Basic Information, Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 85. GSK Pneumococcal Vaccine Product Portfolios and Specifications
Table 86. GSK Pneumococcal Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 87. GSK Main Business
Table 88. GSK Latest Developments
Table 89. MSD Basic Information, Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 90. MSD Pneumococcal Vaccine Product Portfolios and Specifications
Table 91. MSD Pneumococcal Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 92. MSD Main Business
Table 93. MSD Latest Developments
Table 94. Sanofipasteur Basic Information, Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 95. Sanofipasteur Pneumococcal Vaccine Product Portfolios and Specifications
Table 96. Sanofipasteur Pneumococcal Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 97. Sanofipasteur Main Business
Table 98. Sanofipasteur Latest Developments
Table 99. CDIBP Basic Information, Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 100. CDIBP Pneumococcal Vaccine Product Portfolios and Specifications
Table 101. CDIBP Pneumococcal Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 102. CDIBP Main Business
Table 103. CDIBP Latest Developments
Table 1. Pneumococcal Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Pneumococcal Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of PPSV 23
Table 4. Major Players of PCV 7/13
Table 5. Major Players of PCV 10
Table 6. Global Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)
Table 7. Global Pneumococcal Vaccine Sales Market Share by Type (2019-2024)
Table 8. Global Pneumococcal Vaccine Revenue by Type (2019-2024) & ($ million)
Table 9. Global Pneumococcal Vaccine Revenue Market Share by Type (2019-2024)
Table 10. Global Pneumococcal Vaccine Sale Price by Type (2019-2024) & (USD/Dose)
Table 11. Global Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)
Table 12. Global Pneumococcal Vaccine Sales Market Share by End User (2019-2024)
Table 13. Global Pneumococcal Vaccine Revenue by End User (2019-2024)
Table 14. Global Pneumococcal Vaccine Revenue Market Share by End User (2019-2024)
Table 15. Global Pneumococcal Vaccine Sale Price by End User (2019-2024) & (USD/Dose)
Table 16. Global Pneumococcal Vaccine Sales by Company (2019-2024) & (K Doses)
Table 17. Global Pneumococcal Vaccine Sales Market Share by Company (2019-2024)
Table 18. Global Pneumococcal Vaccine Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Pneumococcal Vaccine Revenue Market Share by Company (2019-2024)
Table 20. Global Pneumococcal Vaccine Sale Price by Company (2019-2024) & (USD/Dose)
Table 21. Key Manufacturers Pneumococcal Vaccine Producing Area Distribution and Sales Area
Table 22. Players Pneumococcal Vaccine Products Offered
Table 23. Pneumococcal Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Pneumococcal Vaccine Sales by Geographic Region (2019-2024) & (K Doses)
Table 27. Global Pneumococcal Vaccine Sales Market Share Geographic Region (2019-2024)
Table 28. Global Pneumococcal Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Pneumococcal Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Pneumococcal Vaccine Sales by Country/Region (2019-2024) & (K Doses)
Table 31. Global Pneumococcal Vaccine Sales Market Share by Country/Region (2019-2024)
Table 32. Global Pneumococcal Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Pneumococcal Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Pneumococcal Vaccine Sales by Country (2019-2024) & (K Doses)
Table 35. Americas Pneumococcal Vaccine Sales Market Share by Country (2019-2024)
Table 36. Americas Pneumococcal Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Pneumococcal Vaccine Revenue Market Share by Country (2019-2024)
Table 38. Americas Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)
Table 39. Americas Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)
Table 40. APAC Pneumococcal Vaccine Sales by Region (2019-2024) & (K Doses)
Table 41. APAC Pneumococcal Vaccine Sales Market Share by Region (2019-2024)
Table 42. APAC Pneumococcal Vaccine Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Pneumococcal Vaccine Revenue Market Share by Region (2019-2024)
Table 44. APAC Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)
Table 45. APAC Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)
Table 46. Europe Pneumococcal Vaccine Sales by Country (2019-2024) & (K Doses)
Table 47. Europe Pneumococcal Vaccine Sales Market Share by Country (2019-2024)
Table 48. Europe Pneumococcal Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Pneumococcal Vaccine Revenue Market Share by Country (2019-2024)
Table 50. Europe Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)
Table 51. Europe Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)
Table 52. Middle East & Africa Pneumococcal Vaccine Sales by Country (2019-2024) & (K Doses)
Table 53. Middle East & Africa Pneumococcal Vaccine Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Pneumococcal Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Pneumococcal Vaccine Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)
Table 57. Middle East & Africa Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)
Table 58. Key Market Drivers & Growth Opportunities of Pneumococcal Vaccine
Table 59. Key Market Challenges & Risks of Pneumococcal Vaccine
Table 60. Key Industry Trends of Pneumococcal Vaccine
Table 61. Pneumococcal Vaccine Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Pneumococcal Vaccine Distributors List
Table 64. Pneumococcal Vaccine Customer List
Table 65. Global Pneumococcal Vaccine Sales Forecast by Region (2025-2030) & (K Doses)
Table 66. Global Pneumococcal Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Pneumococcal Vaccine Sales Forecast by Country (2025-2030) & (K Doses)
Table 68. Americas Pneumococcal Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Pneumococcal Vaccine Sales Forecast by Region (2025-2030) & (K Doses)
Table 70. APAC Pneumococcal Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Pneumococcal Vaccine Sales Forecast by Country (2025-2030) & (K Doses)
Table 72. Europe Pneumococcal Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Pneumococcal Vaccine Sales Forecast by Country (2025-2030) & (K Doses)
Table 74. Middle East & Africa Pneumococcal Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Pneumococcal Vaccine Sales Forecast by Type (2025-2030) & (K Doses)
Table 76. Global Pneumococcal Vaccine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Pneumococcal Vaccine Sales Forecast by End User (2025-2030) & (K Doses)
Table 78. Global Pneumococcal Vaccine Revenue Forecast by End User (2025-2030) & ($ Millions)
Table 79. Pfizer Basic Information, Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 80. Pfizer Pneumococcal Vaccine Product Portfolios and Specifications
Table 81. Pfizer Pneumococcal Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 82. Pfizer Main Business
Table 83. Pfizer Latest Developments
Table 84. GSK Basic Information, Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 85. GSK Pneumococcal Vaccine Product Portfolios and Specifications
Table 86. GSK Pneumococcal Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 87. GSK Main Business
Table 88. GSK Latest Developments
Table 89. MSD Basic Information, Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 90. MSD Pneumococcal Vaccine Product Portfolios and Specifications
Table 91. MSD Pneumococcal Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 92. MSD Main Business
Table 93. MSD Latest Developments
Table 94. Sanofipasteur Basic Information, Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 95. Sanofipasteur Pneumococcal Vaccine Product Portfolios and Specifications
Table 96. Sanofipasteur Pneumococcal Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 97. Sanofipasteur Main Business
Table 98. Sanofipasteur Latest Developments
Table 99. CDIBP Basic Information, Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 100. CDIBP Pneumococcal Vaccine Product Portfolios and Specifications
Table 101. CDIBP Pneumococcal Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 102. CDIBP Main Business
Table 103. CDIBP Latest Developments
LIST OF FIGURES
Figure 1. Picture of Pneumococcal Vaccine
Figure 2. Pneumococcal Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pneumococcal Vaccine Sales Growth Rate 2019-2030 (K Doses)
Figure 7. Global Pneumococcal Vaccine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Pneumococcal Vaccine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of PPSV 23
Figure 10. Product Picture of PCV 7/13
Figure 11. Product Picture of PCV 10
Figure 12. Global Pneumococcal Vaccine Sales Market Share by Type in 2023
Figure 13. Global Pneumococcal Vaccine Revenue Market Share by Type (2019-2024)
Figure 14. Pneumococcal Vaccine Consumed in Child
Figure 15. Global Pneumococcal Vaccine Market: Child (2019-2024) & (K Doses)
Figure 16. Pneumococcal Vaccine Consumed in Adult
Figure 17. Global Pneumococcal Vaccine Market: Adult (2019-2024) & (K Doses)
Figure 18. Global Pneumococcal Vaccine Sales Market Share by End User (2023)
Figure 19. Global Pneumococcal Vaccine Revenue Market Share by End User in 2023
Figure 20. Pneumococcal Vaccine Sales Market by Company in 2023 (K Doses)
Figure 21. Global Pneumococcal Vaccine Sales Market Share by Company in 2023
Figure 22. Pneumococcal Vaccine Revenue Market by Company in 2023 ($ Million)
Figure 23. Global Pneumococcal Vaccine Revenue Market Share by Company in 2023
Figure 24. Global Pneumococcal Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 25. Global Pneumococcal Vaccine Revenue Market Share by Geographic Region in 2023
Figure 26. Americas Pneumococcal Vaccine Sales 2019-2024 (K Doses)
Figure 27. Americas Pneumococcal Vaccine Revenue 2019-2024 ($ Millions)
Figure 28. APAC Pneumococcal Vaccine Sales 2019-2024 (K Doses)
Figure 29. APAC Pneumococcal Vaccine Revenue 2019-2024 ($ Millions)
Figure 30. Europe Pneumococcal Vaccine Sales 2019-2024 (K Doses)
Figure 31. Europe Pneumococcal Vaccine Revenue 2019-2024 ($ Millions)
Figure 32. Middle East & Africa Pneumococcal Vaccine Sales 2019-2024 (K Doses)
Figure 33. Middle East & Africa Pneumococcal Vaccine Revenue 2019-2024 ($ Millions)
Figure 34. Americas Pneumococcal Vaccine Sales Market Share by Country in 2023
Figure 35. Americas Pneumococcal Vaccine Revenue Market Share by Country in 2023
Figure 36. Americas Pneumococcal Vaccine Sales Market Share by Type (2019-2024)
Figure 37. Americas Pneumococcal Vaccine Sales Market Share by End User (2019-2024)
Figure 38. United States Pneumococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 39. Canada Pneumococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 40. Mexico Pneumococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 41. Brazil Pneumococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 42. APAC Pneumococcal Vaccine Sales Market Share by Region in 2023
Figure 43. APAC Pneumococcal Vaccine Revenue Market Share by Regions in 2023
Figure 44. APAC Pneumococcal Vaccine Sales Market Share by Type (2019-2024)
Figure 45. APAC Pneumococcal Vaccine Sales Market Share by End User (2019-2024)
Figure 46. China Pneumococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 47. Japan Pneumococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 48. South Korea Pneumococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 49. Southeast Asia Pneumococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 50. India Pneumococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 51. Australia Pneumococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 52. China Taiwan Pneumococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 53. Europe Pneumococcal Vaccine Sales Market Share by Country in 2023
Figure 54. Europe Pneumococcal Vaccine Revenue Market Share by Country in 2023
Figure 55. Europe Pneumococcal Vaccine Sales Market Share by Type (2019-2024)
Figure 56. Europe Pneumococcal Vaccine Sales Market Share by End User (2019-2024)
Figure 57. Germany Pneumococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 58. France Pneumococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 59. UK Pneumococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 60. Italy Pneumococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 61. Russia Pneumococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 62. Middle East & Africa Pneumococcal Vaccine Sales Market Share by Country in 2023
Figure 63. Middle East & Africa Pneumococcal Vaccine Revenue Market Share by Country in 2023
Figure 64. Middle East & Africa Pneumococcal Vaccine Sales Market Share by Type (2019-2024)
Figure 65. Middle East & Africa Pneumococcal Vaccine Sales Market Share by End User (2019-2024)
Figure 66. Egypt Pneumococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 67. South Africa Pneumococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 68. Israel Pneumococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 69. Turkey Pneumococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 70. GCC Country Pneumococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Pneumococcal Vaccine in 2023
Figure 72. Manufacturing Process Analysis of Pneumococcal Vaccine
Figure 73. Industry Chain Structure of Pneumococcal Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Pneumococcal Vaccine Sales Market Forecast by Region (2025-2030)
Figure 76. Global Pneumococcal Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 77. Global Pneumococcal Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 78. Global Pneumococcal Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 79. Global Pneumococcal Vaccine Sales Market Share Forecast by End User (2025-2030)
Figure 80. Global Pneumococcal Vaccine Revenue Market Share Forecast by End User (2025-2030)
Figure 1. Picture of Pneumococcal Vaccine
Figure 2. Pneumococcal Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pneumococcal Vaccine Sales Growth Rate 2019-2030 (K Doses)
Figure 7. Global Pneumococcal Vaccine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Pneumococcal Vaccine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of PPSV 23
Figure 10. Product Picture of PCV 7/13
Figure 11. Product Picture of PCV 10
Figure 12. Global Pneumococcal Vaccine Sales Market Share by Type in 2023
Figure 13. Global Pneumococcal Vaccine Revenue Market Share by Type (2019-2024)
Figure 14. Pneumococcal Vaccine Consumed in Child
Figure 15. Global Pneumococcal Vaccine Market: Child (2019-2024) & (K Doses)
Figure 16. Pneumococcal Vaccine Consumed in Adult
Figure 17. Global Pneumococcal Vaccine Market: Adult (2019-2024) & (K Doses)
Figure 18. Global Pneumococcal Vaccine Sales Market Share by End User (2023)
Figure 19. Global Pneumococcal Vaccine Revenue Market Share by End User in 2023
Figure 20. Pneumococcal Vaccine Sales Market by Company in 2023 (K Doses)
Figure 21. Global Pneumococcal Vaccine Sales Market Share by Company in 2023
Figure 22. Pneumococcal Vaccine Revenue Market by Company in 2023 ($ Million)
Figure 23. Global Pneumococcal Vaccine Revenue Market Share by Company in 2023
Figure 24. Global Pneumococcal Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 25. Global Pneumococcal Vaccine Revenue Market Share by Geographic Region in 2023
Figure 26. Americas Pneumococcal Vaccine Sales 2019-2024 (K Doses)
Figure 27. Americas Pneumococcal Vaccine Revenue 2019-2024 ($ Millions)
Figure 28. APAC Pneumococcal Vaccine Sales 2019-2024 (K Doses)
Figure 29. APAC Pneumococcal Vaccine Revenue 2019-2024 ($ Millions)
Figure 30. Europe Pneumococcal Vaccine Sales 2019-2024 (K Doses)
Figure 31. Europe Pneumococcal Vaccine Revenue 2019-2024 ($ Millions)
Figure 32. Middle East & Africa Pneumococcal Vaccine Sales 2019-2024 (K Doses)
Figure 33. Middle East & Africa Pneumococcal Vaccine Revenue 2019-2024 ($ Millions)
Figure 34. Americas Pneumococcal Vaccine Sales Market Share by Country in 2023
Figure 35. Americas Pneumococcal Vaccine Revenue Market Share by Country in 2023
Figure 36. Americas Pneumococcal Vaccine Sales Market Share by Type (2019-2024)
Figure 37. Americas Pneumococcal Vaccine Sales Market Share by End User (2019-2024)
Figure 38. United States Pneumococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 39. Canada Pneumococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 40. Mexico Pneumococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 41. Brazil Pneumococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 42. APAC Pneumococcal Vaccine Sales Market Share by Region in 2023
Figure 43. APAC Pneumococcal Vaccine Revenue Market Share by Regions in 2023
Figure 44. APAC Pneumococcal Vaccine Sales Market Share by Type (2019-2024)
Figure 45. APAC Pneumococcal Vaccine Sales Market Share by End User (2019-2024)
Figure 46. China Pneumococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 47. Japan Pneumococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 48. South Korea Pneumococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 49. Southeast Asia Pneumococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 50. India Pneumococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 51. Australia Pneumococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 52. China Taiwan Pneumococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 53. Europe Pneumococcal Vaccine Sales Market Share by Country in 2023
Figure 54. Europe Pneumococcal Vaccine Revenue Market Share by Country in 2023
Figure 55. Europe Pneumococcal Vaccine Sales Market Share by Type (2019-2024)
Figure 56. Europe Pneumococcal Vaccine Sales Market Share by End User (2019-2024)
Figure 57. Germany Pneumococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 58. France Pneumococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 59. UK Pneumococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 60. Italy Pneumococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 61. Russia Pneumococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 62. Middle East & Africa Pneumococcal Vaccine Sales Market Share by Country in 2023
Figure 63. Middle East & Africa Pneumococcal Vaccine Revenue Market Share by Country in 2023
Figure 64. Middle East & Africa Pneumococcal Vaccine Sales Market Share by Type (2019-2024)
Figure 65. Middle East & Africa Pneumococcal Vaccine Sales Market Share by End User (2019-2024)
Figure 66. Egypt Pneumococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 67. South Africa Pneumococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 68. Israel Pneumococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 69. Turkey Pneumococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 70. GCC Country Pneumococcal Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Pneumococcal Vaccine in 2023
Figure 72. Manufacturing Process Analysis of Pneumococcal Vaccine
Figure 73. Industry Chain Structure of Pneumococcal Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Pneumococcal Vaccine Sales Market Forecast by Region (2025-2030)
Figure 76. Global Pneumococcal Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 77. Global Pneumococcal Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 78. Global Pneumococcal Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 79. Global Pneumococcal Vaccine Sales Market Share Forecast by End User (2025-2030)
Figure 80. Global Pneumococcal Vaccine Revenue Market Share Forecast by End User (2025-2030)
